Everest Pharmaceuticals Ltd. is a pharmaceutical company based in Bangladesh and is identified by its official product catalogue as the manufacturer associated with Osimert, an osimertinib 80 mg product.
Company background
Everest Pharmaceuticals describes itself as a vertically integrated pharmaceutical company involved in technology-driven medicines and specialized pharmaceutical areas, including oncology, nephrology, hematology, virology and biotechnology-related products.
Manufacturing location
The company identifies its manufacturing plant at:
Everest Pharmaceuticals Limited
Rahman’s Regnum Centre (1 0th & 11th Floor)
1 91/1, Bir Uttam Mir Shawkat Sarak,Tejgaon
Dhaka-1208, Bangladesh
Quality information
Everest states that its quality policy includes adherence to cGMP principles and efforts toward pharmaceutical quality standards. This is a statement made by the manufacturer and should not be interpreted as an independent certification unless the specific certificate or regulatory record is separately verified.
Osimert product relationship
Everest’s official product catalogue lists:
Osimert — Osimertinib INN 80 mg.
This establishes the manufacturer’s stated product relationship.
Manufacturer versus originator
Everest Pharmaceuticals should not be described as the originator of osimertinib.
The original reference product Tagrisso was developed and marketed by AstraZeneca. Osimert is a separate product containing the same active pharmaceutical ingredient, osimertinib.
Corporate information
The company’s official contact information identifies its head office in Dhaka and its manufacturing plant in Narayanganj.